Predicting Advanced Prostate Cancer from Modeling Early Indications in Biopsy and Prostatectomy Samples via Transductive Semi-Supervised Survival Analysis

Table 3

Weights of features in models.

	Cox Model		Cox Model with Transduction		SVRc		SVRc with Transduction
Feature	Original Weight	Normalized Weight	Original Weight	Normalized Weight	Original Weight	Normalized Weight	Original Weight	Normalized Weight
Clinical Stage	0.314	0.217	0.355	0.316	-2.939	-0.12	-4.496	-0.197
PSA	0.743	0.513	0.818	0.728	-10.329	-0.423	-8.397	-0.368
Dominant Biopsy Gleason Grade	-0.198	-0.137	0.134	0.119	-3.909	-0.16	-8.193	-0.359
Biopsy Gleason Sum	1.448	1	1.124	1	-24.394	-1	-22.826	-1
Dominant Prostatectomy Gleason Grade	0.872	0.602	1.002	0.891	-4.363	-0.179	-6.433	-0.282
Prostatectomy Gleason Sum	0.073	0.05	-0.139	-0.123	-11.852	-0.486	-8.784	-0.385
Seminal Vesicle Invasion	0.747	0.516	0.796	0.708	-23.926	-0.981	-25.963	-1.137
Surgical Margin Status	0.306	0.212	0.261	0.232	-2.778	-0.114	-3.964	-0.174
Extra Capsular Extension Status	0.198	0.137	0.161	0.143	-4.259	-0.175	-3.499	-0.153